EE474 Cost-Effectiveness Model for a Novel Functional ASSAY Versus Provider Selection of Third-Line Treatment of Patients with Refractory Metastatic Colorectal Cancer

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.722
https://www.valueinhealthjournal.com/article/S1098-3015(22)00923-8/fulltext
Title : EE474 Cost-Effectiveness Model for a Novel Functional ASSAY Versus Provider Selection of Third-Line Treatment of Patients with Refractory Metastatic Colorectal Cancer
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00923-8&doi=10.1016/j.jval.2022.04.722
First page :
Section Title :
Open access? : No
Section Order : 10653
Categories :
Tags :
Regions :
ViH Article Tags :